Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Farmers Insurance
UBS
Citi
AstraZeneca
Johnson and Johnson
Harvard Business School
Cipla
Julphar

Generated: August 18, 2018

DrugPatentWatch Database Preview

Aspen Global Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ASPEN GLOBAL INC, and what generic and branded alternatives to ASPEN GLOBAL INC drugs are available?

ASPEN GLOBAL INC has eleven approved drugs.



Summary for Aspen Global Inc
US Patents:0
Tradenames:9
Ingredients:10
NDAs:11
Drug Master File Entries: 1

Drugs and US Patents for Aspen Global Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aspen Global Inc DECA-DURABOLIN nandrolone decanoate INJECTABLE;INJECTION 013132-001 Jun 12, 1986 DISCN No No ➤ Sign Up ➤ Sign Up
Aspen Global Inc BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 204713-001 Apr 14, 2015 AA RX No No ➤ Sign Up ➤ Sign Up
Aspen Global Inc DECA-DURABOLIN nandrolone decanoate INJECTABLE;INJECTION 013132-003 Jun 12, 1986 DISCN Yes No ➤ Sign Up ➤ Sign Up
Aspen Global Inc HEXADROL dexamethasone sodium phosphate INJECTABLE;INJECTION 014694-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up
Aspen Global Inc HEXADROL dexamethasone TABLET;ORAL 012675-010 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Aspen Global Inc MYLERAN busulfan INJECTABLE;INJECTION 208536-001 Nov 20, 2017 AP RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Aspen Global Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aspen Global Inc ORGARAN danaparoid sodium INJECTABLE;INJECTION 020430-001 Dec 24, 1996 5,164,377 ➤ Sign Up
Aspen Global Inc CYCLESSA desogestrel; ethinyl estradiol TABLET;ORAL-28 021090-001 Dec 20, 2000 4,616,006 ➤ Sign Up
Aspen Global Inc CYCLESSA desogestrel; ethinyl estradiol TABLET;ORAL-28 021090-001 Dec 20, 2000 4,544,554 ➤ Sign Up
Aspen Global Inc CYCLESSA desogestrel; ethinyl estradiol TABLET;ORAL-28 021090-001 Dec 20, 2000 4,628,051 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Fish and Richardson
Harvard Business School
Queensland Health
McKinsey
Fuji
Dow
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.